HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (189) Citing Articles via Google Scholar Google Scholar Articles by Elliott, R. M. Articles by Marks, V. Search for Related Content PubMed Articles by Elliott, R. M. Articles by Marks, V.

The acute effects of different macronutrients on the secretion of glucagon-like peptide-1(7–36)amide (GLP-1(7–36)amide) and glucose-dependent insulinotropic polypeptide (GIP) were compared in healthy human subjects. Circulating levels of the two hormones were measured over a 24-h period during which subjects consumed a mixed diet. In the first study, eight subjects consumed three equicaloric (375 kcal) test meals of carbohydrate, fat and protein. Small increases in plasma GLP-1(7–36) amide were found after all meals. Levels reached a maximum 30 min after the carbohydrate and 150 min after the fat load. Ingestion of both carbohydrate and fat induced substantial rises in GIP secretion, but the protein meal had no effect. In a second study, eight subjects consumed 75 g glucose or the equivalent portion of complex carbohydrate as boiled brown rice or barley. Plasma GIP, insulin and glucose levels increased after all three meals, the largest increase being observed following glucose and the smallest following the barley meal. Plasma GLP-1(7–36)amide levels rose only following the glucose meal. In the 24-h study, plasma GLP-1(7–36)amide and GIP concentrations were increased following every meal and remained elevated throughout the day, only falling to fasting levels at night. The increases in circulating GLP-1(7–36)amide and GIP levels following carbohydrate or a mixed meal are consistent with their role as incretins. The more sustained rises observed in the daytime during the 24-h study are consistent with an anabolic role in lipid metabolism.

Journal of Endocrinology (1993) 138, 159–166

This article has been cited by other articles:

				S. Huttner, E. U. Graefe-Mody, B. Withopf, A. Ring, and K. A. Dugi Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers J. Clin. Pharmacol., October 1, 2008; 48(10): 1171 - 1178. [Abstract] [Full Text] [PDF]

				R. D. Carr, M. O. Larsen, M. S. Winzell, K. Jelic, O. Lindgren, C. F. Deacon, and B. Ahren Incretin and islet hormonal responses to fat and protein ingestion in healthy men Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E779 - E784. [Abstract] [Full Text] [PDF]

				W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1130 - G1138. [Abstract] [Full Text] [PDF]

				S. R. Bloom, F. P. Kuhajda, I. Laher, X. Pi-Sunyer, G. V. Ronnett, T. M.M. Tan, and D. S. Weigle The Obesity Epidemic: Pharmacological Challenges Mol. Interv., April 1, 2008; 8(2): 82 - 98. [Abstract] [Full Text] [PDF]

				A. Karamanlis, R. Chaikomin, S. Doran, M. Bellon, F D. Bartholomeusz, J. M Wishart, K. L Jones, M. Horowitz, and C. K Rayner Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1364 - 1368. [Abstract] [Full Text] [PDF]

				W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G963 - G971. [Abstract] [Full Text] [PDF]

				J. J. Holst The Physiology of Glucagon-like Peptide 1 Physiol Rev, October 1, 2007; 87(4): 1409 - 1439. [Abstract] [Full Text] [PDF]

				R. Iakoubov, A. Izzo, A. Yeung, C. I. Whiteside, and P. L. Brubaker Protein Kinase C{zeta} Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells Endocrinology, March 1, 2007; 148(3): 1089 - 1098. [Abstract] [Full Text] [PDF]

				F. K. Knop, T. Vilsboll, S. Larsen, P. V. Hojberg, A. Volund, S. Madsbad, J. J. Holst, and T. Krarup Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E324 - E330. [Abstract] [Full Text] [PDF]

				G. E. Lim and P. L. Brubaker Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within Diabetes, December 1, 2006; 55(Supplement_2): S70 - S77. [Abstract] [Full Text] [PDF]

				F. Reimann, P. S. Ward, and F. M. Gribble Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1 Diabetes, December 1, 2006; 55(Supplement_2): S78 - S85. [Abstract] [Full Text] [PDF]

				R. A Reimer Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. J. Endocrinol., October 1, 2006; 191(1): 159 - 170. [Abstract] [Full Text] [PDF]

				J. Bowen, M. Noakes, and P. M. Clifton Appetite Regulatory Hormone Responses to Various Dietary Proteins Differ by Body Mass Index Status Despite Similar Reductions in ad Libitum Energy Intake J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2913 - 2919. [Abstract] [Full Text] [PDF]

				P. T. Gunnarsson, M. S. Winzell, C. F. Deacon, M. O. Larsen, K. Jelic, R. D. Carr, and B. Ahren Glucose-Induced Incretin Hormone Release and Inactivation Are Differently Modulated by Oral Fat and Protein in Mice Endocrinology, July 1, 2006; 147(7): 3173 - 3180. [Abstract] [Full Text] [PDF]

				M. J. Theodorakis, O. Carlson, S. Michopoulos, M. E. Doyle, M. Juhaszova, K. Petraki, and J. M. Egan Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E550 - E559. [Abstract] [Full Text] [PDF]

				W. A. Blom, A. Lluch, A. Stafleu, S. Vinoy, J. J Holst, G. Schaafsma, and H. F. Hendriks Effect of a high-protein breakfast on the postprandial ghrelin response Am. J. Clinical Nutrition, February 1, 2006; 83(2): 211 - 220. [Abstract] [Full Text] [PDF]

				M. P. Lejeune, K. R Westerterp, T. C. Adam, N. D Luscombe-Marsh, and M. S Westerterp-Plantenga Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber Am. J. Clinical Nutrition, January 1, 2006; 83(1): 89 - 94. [Abstract] [Full Text] [PDF]

				B. Stoll, P. T. Price, P. J. Reeds, X. Chang, J. F. Henry, J. B. van Goudoever, J. J. Holst, and D. G. Burrin Feeding an Elemental Diet vs a Milk-Based Formula Does Not Decrease Intestinal Mucosal Growth in Infant Pigs JPEN J Parenter Enteral Nutr, January 1, 2006; 30(1): 32 - 39. [Abstract] [Full Text] [PDF]

				E. M Sinclair and D. J. Drucker Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential Physiology, October 1, 2005; 20(5): 357 - 365. [Abstract] [Full Text] [PDF]

				S. Seino and T. Shibasaki PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis Physiol Rev, October 1, 2005; 85(4): 1303 - 1342. [Abstract] [Full Text] [PDF]

				A. H Frid, M. Nilsson, J. J. Holst, and I. M. Bjorck Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects Am. J. Clinical Nutrition, July 1, 2005; 82(1): 69 - 75. [Abstract] [Full Text] [PDF]

				S. Stock, P. Leichner, A. C. K. Wong, M. A. Ghatei, T. J. Kieffer, S. R. Bloom, and J.-P. Chanoine Ghrelin, Peptide YY, Glucose-Dependent Insulinotropic Polypeptide, and Hunger Responses to a Mixed Meal in Anorexic, Obese, and Control Female Adolescents J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2161 - 2168. [Abstract] [Full Text] [PDF]

				T. Miki, K. Minami, H. Shinozaki, K. Matsumura, A. Saraya, H. Ikeda, Y. Yamada, J. J. Holst, and S. Seino Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility Diabetes, April 1, 2005; 54(4): 1056 - 1063. [Abstract] [Full Text] [PDF]

				S. V Joy, P. T Rodgers, and A. C Scates Incretin Mimetics as Emerging Treatments for Type 2 Diabetes Ann. Pharmacother., January 1, 2005; 39(1): 110 - 118. [Abstract] [Full Text] [PDF]

				L. Hansen, S. Lampert, H. Mineo, and J. J. Holst Neural regulation of glucagon-like peptide-1 secretion in pigs Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E939 - E947. [Abstract] [Full Text] [PDF]

				S. L. Aronoff, K. Berkowitz, B. Shreiner, and L. Want Glucose Metabolism and Regulation: Beyond Insulin and Glucagon Diabetes Spectr, July 1, 2004; 17(3): 183 - 190. [Abstract] [Full Text] [PDF]

				C. de Graaf, W. A. Blom, P. A. Smeets, A. Stafleu, and H. F. Hendriks Biomarkers of satiation and satiety Am. J. Clinical Nutrition, June 1, 2004; 79(6): 946 - 961. [Abstract] [Full Text] [PDF]

				T. Damci, S. Yalin, H. Balci, Z. Osar, U. Korugan, M. Ozyazar, and H. Ilkova Orlistat Augments Postprandial Increases in Glucagon-like Peptide 1 in Obese Type 2 Diabetic Patients Diabetes Care, May 1, 2004; 27(5): 1077 - 1080. [Abstract] [Full Text] [PDF]

				K. L Johnston, M. N Clifford, and L. M Morgan Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine Am. J. Clinical Nutrition, October 1, 2003; 78(4): 728 - 733. [Abstract] [Full Text] [PDF]

				J. W. Ensinck, E. C. Laschansky, R. E. Vogel, and D. A. D'Alessio Effect of Ingested Nutrients on the Release of Thrittene into the Human Circulation J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4798 - 4804. [Abstract] [Full Text] [PDF]

				D. J. Drucker Enhancing Incretin Action for the Treatment of Type 2 Diabetes Diabetes Care, October 1, 2003; 26(10): 2929 - 2940. [Abstract] [Full Text] [PDF]

				Y. Anini and P. L. Brubaker Muscarinic Receptors Control Glucagon-Like Peptide 1 Secretion by Human Endocrine L Cells Endocrinology, July 1, 2003; 144(7): 3244 - 3250. [Abstract] [Full Text] [PDF]

				A. Aziz and G. H. Anderson Exendin-4, a GLP-1 Receptor Agonist, Interacts with Proteins and Their Products of Digestion to Suppress Food Intake in Rats J. Nutr., July 1, 2003; 133(7): 2326 - 2330. [Abstract] [Full Text] [PDF]

				F. M. Gribble, L. Williams, A. K. Simpson, and F. Reimann A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line Diabetes, May 1, 2003; 52(5): 1147 - 1154. [Abstract] [Full Text] [PDF]

				B. W. Wolf, K. A. Garleb, Y. S. Choe, P. M. Humphrey, and K. C. Maki Pullulan Is a Slowly Digested Carbohydrate in Humans J. Nutr., April 1, 2003; 133(4): 1051 - 1055. [Abstract] [Full Text] [PDF]

				Y. Anini and P. L. Brubaker Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion Diabetes, February 1, 2003; 52(2): 252 - 259. [Abstract] [Full Text] [PDF]

				G. W. Van Citters, M. Kabir, S. P. Kim, S. D. Mittelman, M. K. Dea, P. L. Brubaker, and R. N. Bergman Elevated Glucagon-Like Peptide-1-(7-36)-Amide, but Not Glucose, Associated with Hyperinsulinemic Compensation for Fat Feeding J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5191 - 5198. [Abstract] [Full Text] [PDF]

				B. Rolin, M. O. Larsen, C. F. Gotfredsen, C. F. Deacon, R. D. Carr, M. Wilken, and L. B. Knudsen The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta -cell mass in diabetic mice Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E745 - E752. [Abstract] [Full Text] [PDF]

				A. A. Hardikar, X. Y. Wang, L. J. Williams, J. Kwok, R. Wong, M. Yao, and B. E. Tuch Functional Maturation of Fetal Porcine {beta}-Cells by Glucagon-Like Peptide 1 and Cholecystokinin Endocrinology, September 1, 2002; 143(9): 3505 - 3514. [Abstract] [Full Text] [PDF]

				F. Reimann and F. M. Gribble Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells Diabetes, September 1, 2002; 51(9): 2757 - 2763. [Abstract] [Full Text] [PDF]

				M D. Robertson, K. G Jackson, B. A Fielding, L. M Morgan, C. M Williams, and K. N Frayn Acute ingestion of a meal rich in n-3 polyunsaturated fatty acids results in rapid gastric emptying in humans Am. J. Clinical Nutrition, July 1, 2002; 76(1): 232 - 238. [Abstract] [Full Text] [PDF]

				Y. Anini, T. Hansotia, and P. L. Brubaker Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats Endocrinology, June 1, 2002; 143(6): 2420 - 2426. [Abstract] [Full Text] [PDF]

				A. Aziz and G. H. Anderson Exendin-4, a GLP-1 Receptor Agonist, Modulates the Effect of Macronutrients on Food Intake by Rats J. Nutr., May 1, 2002; 132(5): 990 - 995. [Abstract] [Full Text] [PDF]

				R. A. Reimer, C. Darimont, S. Gremlich, V. Nicolas-Metral, U. T. Ruegg, and K. Mace A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion Endocrinology, October 1, 2001; 142(10): 4522 - 4528. [Abstract] [Full Text] [PDF]

				Y.-H. Choi and G. H. Anderson An Interaction between Hypothalamic Glucagon-Like Peptide-1 and Macronutrient Composition Determines Food Intake in Rats J. Nutr., June 1, 2001; 131(6): 1819 - 1825. [Abstract] [Full Text]

				A. S. Rocca, J. LaGreca, J. Kalitsky, and P. L. Brubaker Monounsaturated Fatty Acid Diets Improve Glycemic Tolerance through Increased Secretion of Glucagon-Like Peptide-1 Endocrinology, March 1, 2001; 142(3): 1148 - 1155. [Abstract] [Full Text] [PDF]

				L. Baggio, T. J. Kieffer, and D. J. Drucker Glucagon-Like Peptide-1, But Not Glucose-Dependent Insulinotropic Peptide, Regulates Fasting Glycemia and Nonenteral Glucose Clearance in Mice Endocrinology, October 1, 2000; 141(10): 3703 - 3709. [Abstract] [Full Text] [PDF]

				J. T. Lewis, B. Dayanandan, J. F. Habener, and T. J. Kieffer Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist Endocrinology, October 1, 2000; 141(10): 3710 - 3716. [Abstract] [Full Text] [PDF]

				M. A. Gulpinar, A. Bozkurt, T. Coskun, N. B. Ulusoy, and B. C. Yegen Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G924 - G929. [Abstract] [Full Text] [PDF]

				L. Hansen, B. Hartmann, T. Bisgaard, H. Mineo, P. N. Jorgensen, and J. J. Holst Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1010 - E1018. [Abstract] [Full Text] [PDF]

				K. G Jackson, A. Zampelas, J. M. Knapper, H. M Roche, M. J Gibney, A. Kafatos, B. J Gould, J. W Wright, and C. M Williams Differences in glucose-dependent insulinotrophic polypeptide hormone and hepatic lipase in subjects of southern and northern Europe: implications for postprandial lipemia Am. J. Clinical Nutrition, January 1, 2000; 71(1): 13 - 20. [Abstract] [Full Text] [PDF]

				C. Chapman, L. M. Morgan, and M. C. Murphy Maternal and Early Dietary Fatty Acid Intake: Changes in Lipid Metabolism and Liver Enzymes in Adult Rats J. Nutr., January 1, 2000; 130(2): 146 - 151. [Abstract] [Full Text]

				K. Miyawaki, Y. Yamada, H. Yano, H. Niwa, N. Ban, Y. Ihara, A. Kubota, S. Fujimoto, M. Kajikawa, A. Kuroe, et al. Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice PNAS, December 21, 1999; 96(26): 14843 - 14847. [Abstract] [Full Text] [PDF]

				T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]

				N. M. Delzenne and N. N. Kok Biochemical Basis of Oligofructose-Induced Hypolipidemia in Animal Models J. Nutr., July 1, 1999; 129(7): 1467 - 1467. [Abstract] [Full Text]

				C.-C. Tseng, X.-Y. Zhang, and M. M. Wolfe Effect of GIP and GLP-1 antagonists on insulin release in the rat Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1049 - E1054. [Abstract] [Full Text] [PDF]

				A. S. Rocca and P. L. Brubaker Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion Endocrinology, April 1, 1999; 140(4): 1687 - 1694. [Abstract] [Full Text]

				A. Edvell and P. Lindström Initiation of Increased Pancreatic Islet Growth in Young Normoglycemic Mice (Umea +/?) Endocrinology, February 1, 1999; 140(2): 778 - 783. [Abstract] [Full Text]

				A. Wettergren, M. Wojdemann, and J. J. Holst Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G984 - G992. [Abstract] [Full Text] [PDF]

				N. N. Kok, L. M. Morgan, C. M. Williams, M. B. Roberfroid, J.-P. Thissen, and N. M. Delzenne Insulin, Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Insulin-Like Growth Factor I as Putative Mediators of the Hypolipidemic Effect of Oligofructose in Rats J. Nutr., July 1, 1998; 128(7): 1099 - 1103. [Abstract] [Full Text] [PDF]

A. B. Damholt, A. M. J. Buchan, and H. Kofod Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose Endocrinology, April 1, 1998; 139(4): 2085 - 2091.